NU Skin Enterprises Inc.

N/A : NUS
Pharmaceuticals
Provo UT
Revenue (US$ Millions)$2,569
Revenue Growth (%)-19.11%
Net Income (Millions)$189
Common Shares Outstanding (Millions)$59
Earnings per Share$3.11
Price To Earnings Ratio43.19
Total Equity (Millions)$942
Profit Margin 17.36%
Return on Equity22.03%
Long Term Debt (US$ Millions)$165
Debt To Equity Ratio (%)0.17%
Market Capitalization (US$ Millions)$2,578
Total Assets (US$ Millions)$1,614
Return on Assets (%)10.39
Current Assets (US$ Millions)$835
Inventories (US$ Millions)$338
Current Liabilities (US$ Millions)$418
Cost of Goods Sold (US$ Millions)$478
Asset Turnover1.59
Inventory Turnover1.41